Appnea

APPNEA: Transforming Sleep Medicine, TMD & Orofacial Pain Management with AI-Driven Innovation APPNEA.AI is a next-generation MedTech platform dedicated to revolutionizing the diagnosis and treatment of sleep apnea—a condition affecting nearly 70 million americans and 1 billion people worldwide, yet still largely underdiagnosed and undertreated. Our AI-powered ecosystem integrates cloud-based sleep testing, intelligent diagnostics, and personalized treatment pathways into a seamless platform for physicians, dentists, and patients. At the core of APPNEA.AI is our proprietary AI-enabled Practice Management System (PMS) and Electronic Health Record (EHR), specifically designed for sleep medicine, dental sleep medicine and temporomandibular joint disorders (TMD) and orofacial pain (OFP) management. By unifying clinical data, digital workflows, and predictive algorithms, we streamline patient care from screening to treatment to long-term compliance. The result is improved practice efficiency and increased revenue for providers, lower costs for payers, and life-changing outcomes for patients. The platform leverages machine learning, AI and digital medical logistics (DML) to optimize patient engagement, automate testing coordination, and support evidence-based treatment selection—including oral appliance therapy and integrated medical-dental solutions. For patients, APPNEA.AI delivers a simple, accessible, and personalized experience that drives adherence and better health outcomes. For providers, it offers scalability, advanced practice analytics, and reimbursement optimization. From a market perspective, APPNEA.AI addresses a multi-billion-dollar global opportunity spanning diagnostics, therapeutics, and digital health services. With an estimated TAM exceeding $50B, the platform is positioned to disrupt traditional care models by enabling scalable, cost-effective, AI-powered sleep and TMD care.